Put Options

22 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$187.96 - $245.29 $112,776 - $147,174
-600 Reduced 21.43%
2,200 $433,000
Q2 2024

Aug 14, 2024

SELL
$206.39 - $268.73 $6.21 Million - $8.09 Million
-30,100 Reduced 91.49%
2,800 $578,000
Q1 2024

May 15, 2024

BUY
$203.52 - $273.43 $142,464 - $191,401
700 Added 2.17%
32,900 $8.91 Million
Q4 2023

Feb 14, 2024

SELL
$164.52 - $238.84 $1.27 Million - $1.84 Million
-7,700 Reduced 19.3%
32,200 $7.61 Million
Q3 2023

Nov 14, 2023

BUY
$194.44 - $217.61 $4.12 Million - $4.61 Million
21,200 Added 113.37%
39,900 $7.82 Million
Q2 2023

Aug 14, 2023

BUY
$183.71 - $210.25 $1.84 Million - $2.1 Million
10,000 Added 114.94%
18,700 $3.93 Million
Q1 2023

May 15, 2023

BUY
$191.89 - $259.92 $1.02 Million - $1.38 Million
5,300 Added 155.88%
8,700 $1.76 Million
Q4 2022

Feb 14, 2023

BUY
$197.11 - $250.07 $591,330 - $750,210
3,000 Added 750.0%
3,400 $740,000
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $72,976 - $100,216
400 New
400 $79,000
Q3 2021

Nov 15, 2021

SELL
$372.64 - $458.3 $819,808 - $1.01 Million
-2,200 Reduced 75.86%
700 $289,000
Q2 2021

Aug 16, 2021

BUY
$294.17 - $371.65 $117,668 - $148,660
400 Added 16.0%
2,900 $1.07 Million
Q1 2021

May 17, 2021

SELL
$249.67 - $299.48 $74,901 - $89,844
-300 Reduced 10.71%
2,500 $725,000
Q4 2020

Feb 16, 2021

BUY
$222.0 - $252.62 $244,200 - $277,882
1,100 Added 64.71%
2,800 $700,000
Q3 2020

Nov 16, 2020

BUY
$175.56 - $226.45 $210,672 - $271,740
1,200 Added 240.0%
1,700 $385,000
Q2 2020

Aug 14, 2020

BUY
$118.84 - $189.72 $23,768 - $37,944
200 Added 66.67%
500 $87,000
Q1 2020

May 15, 2020

SELL
$98.9 - $178.34 $49,450 - $89,170
-500 Reduced 62.5%
300 $38,000
Q4 2019

Feb 14, 2020

BUY
$126.05 - $152.76 $63,025 - $76,380
500 Added 166.67%
800 $122,000
Q3 2019

Nov 14, 2019

BUY
$125.07 - $143.67 $12,507 - $14,366
100 Added 50.0%
300 $40,000
Q2 2019

Aug 14, 2019

BUY
$123.4 - $148.55 $12,340 - $14,855
100 Added 100.0%
200 $28,000
Q1 2019

May 15, 2019

SELL
$104.82 - $146.73 $220,122 - $308,133
-2,100 Reduced 95.45%
100 $15,000
Q4 2018

Feb 14, 2019

SELL
$105.09 - $137.23 $357,306 - $466,581
-3,400 Reduced 60.71%
2,200 $249,000
Q3 2018

Nov 14, 2018

BUY
$112.11 - $134.54 $627,816 - $753,424
5,600 New
5,600 $753,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.